Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomized, double-blind, phase 3 trial.

Butts, C; Socinski, M A; Mitchell, P L; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, T E; Bosquée, L; Trigo, J M; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Johansson, G W; Ellis, P; Gladkov, O; Rodrigues Pereira, J; Eberhardt, W E E; Helwig, C; Schröder, A; Shepherd, F; Santoro, A